ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

The first treatment for macular telangiectasia type 2 is set to enter the market following U.S. FDA approval of NT-501 ...

With temperatures soaring, Mumbai ophthalmologists and retina specialists say “protect your eyes” as they caution citizens to ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Have you heard of macular disease? Despite it being the biggest cause of sight loss in the UK, many people remain unaware of ...

Val Nicholson is one of many pensioners forced to scrimp to afford vital eye injections that stop her going blind, but she's ...